Accession Number: | 0000899243-20-019714 |
Date: | 2020-07-17 |
Issuer: | CORCEPT THERAPEUTICS INC (CORT) |
Original Submission Date: |
SWISHER DANIEL N JR
C/O CORCEPT THERAPEUTICS INCORPORATED
149 COMMONWEALTH DRIVE
MENLO PARK, CA 94025
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2020-07-17 | M | 5,000 | a | $6.55 | 5,000 | direct | ||
COMMON STOCK | 2020-07-17 | S | 5,000 | d | $16.48 | 0 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 6.55 | 2020-07-17 | deemed execution date | M | 5,000 (d) | 2025-06-18 | common stock 5,000 | $6.55 | 60,000 | direct |
ID | footnote |
---|---|
f1 | the transaction was made pursuant to a 10b5-1 plan in effect at the time of the transaction. |
f2 | represents the weighted average sale price for the entire number of shares sold. the actual sale prices range from $16.37 to $16.62 per share. detailed information on the exact number of shares sold at each sale price can be obtained from issuer upon request. |
f3 | fully exercisable. |